<?xml version="1.0" encoding="ASCII"?>
<!-- XBRL document created with Praxa -->
<!-- Copyright (c) 2026 Praxa LLC. All Rights Reserved.-->
<!-- Creation Date: 2026-08-14T19:19:50.4445+00:00 -->
<xs:schema targetNamespace="http://adialpharma.com/20260630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:adil="http://adialpharma.com/20260630" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:srt="http://fasb.org/srt/2026" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2026">
  <xs:import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
  <xs:import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2026" schemaLocation="https://xbrl.sec.gov/ecd/2026/ecd-sub-2026.xsd" />
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adil-20260630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adil-20260630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adil-20260630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="adil-20260630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple" />
      <link:roleType roleURI="http://adialpharma.com/20260630/role/DocumentandEntityInformation" id="DocumentandEntityInformation">
        <link:definition>995300 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CondensedConsolidatedBalanceSheetsUnaudited" id="CondensedConsolidatedBalanceSheetsUnaudited">
        <link:definition>995301 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals" id="CondensedConsolidatedBalanceSheetsUnauditedParentheticals">
        <link:definition>995302 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofOperationsUnaudited" id="CondensedConsolidatedStatementsofOperationsUnaudited">
        <link:definition>995303 - Statement - Condensed Consolidated Statements of Operations (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofTemporaryEquityandStockholdersDeficitEquityUnaudited" id="CondensedConsolidatedStatementsofTemporaryEquityandStockholdersDeficitEquityUnaudited">
        <link:definition>995304 - Statement - Condensed Consolidated Statements of Temporary Equity and Stockholders&#8217; (Deficit) Equity (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" id="CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>995305 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/DescriptionofBusiness" id="DescriptionofBusiness">
        <link:definition>995306 - Disclosure - Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/GoingConcernandOtherUncertainties" id="GoingConcernandOtherUncertainties">
        <link:definition>995307 - Disclosure - Going Concern and Other Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" id="BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>995308 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuance" id="AcquisitionofAzoraandPipeIssuance">
        <link:definition>995309 - Disclosure - Acquisition of Azora and Pipe Issuance</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/FairValueMeasurements" id="FairValueMeasurements">
        <link:definition>995310 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/EquityMethodInvestments" id="EquityMethodInvestments">
        <link:definition>995311 - Disclosure - Equity Method Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AccruedExpenses" id="AccruedExpenses">
        <link:definition>995312 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/ConvertiblePreferredStock" id="ConvertiblePreferredStock">
        <link:definition>995313 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquity" id="StockholdersEquity">
        <link:definition>995314 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CommitmentsandContingencies" id="CommitmentsandContingencies">
        <link:definition>995315 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/SegmentReporting" id="SegmentReporting">
        <link:definition>995316 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>996317 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>996318 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceTables" id="AcquisitionofAzoraandPipeIssuanceTables">
        <link:definition>996319 - Disclosure - Acquisition of Azora and Pipe Issuance (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/FairValueMeasurementsTables" id="FairValueMeasurementsTables">
        <link:definition>996320 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/EquityMethodInvestmentsTables" id="EquityMethodInvestmentsTables">
        <link:definition>996321 - Disclosure - Equity Method Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AccruedExpensesTables" id="AccruedExpensesTables">
        <link:definition>996322 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityTables" id="StockholdersEquityTables">
        <link:definition>996323 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/SegmentReportingTables" id="SegmentReportingTables">
        <link:definition>996324 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/DescriptionofBusinessDetails" id="DescriptionofBusinessDetails">
        <link:definition>996325 - Disclosure - Description of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/GoingConcernandOtherUncertaintiesDetails" id="GoingConcernandOtherUncertaintiesDetails">
        <link:definition>996326 - Disclosure - Going Concern and Other Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996327 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveCommonSharesDetails" id="BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveCommonSharesDetails">
        <link:definition>996328 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceDetails" id="AcquisitionofAzoraandPipeIssuanceDetails">
        <link:definition>996329 - Disclosure - Acquisition of Azora and Pipe Issuance - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceScheduleofFairValueofConsiderationTransferredDetails" id="AcquisitionofAzoraandPipeIssuanceScheduleofFairValueofConsiderationTransferredDetails">
        <link:definition>996330 - Disclosure - Acquisition of Azora and Pipe Issuance - Schedule of Fair Value of Consideration Transferred (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceScheduleofAllocationtoEstimatedFairValueofConsiderationTransferredtoNetAssetsDetails" id="AcquisitionofAzoraandPipeIssuanceScheduleofAllocationtoEstimatedFairValueofConsiderationTransferredtoNetAssetsDetails">
        <link:definition>996331 - Disclosure - Acquisition of Azora and Pipe Issuance - Schedule of Allocation to Estimated Fair Value of Consideration Transferred to Net Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/FairValueMeasurementsDetails" id="FairValueMeasurementsDetails">
        <link:definition>996332 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/FairValueMeasurementsScheduleofFairValueoftheMilestoneWarrantLiabilityDetails" id="FairValueMeasurementsScheduleofFairValueoftheMilestoneWarrantLiabilityDetails">
        <link:definition>996333 - Disclosure - Fair Value Measurements - Schedule of Fair Value of the Milestone Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/FairValueMeasurementsScheduleofMilestoneWarrantLiabilityDetails" id="FairValueMeasurementsScheduleofMilestoneWarrantLiabilityDetails">
        <link:definition>996334 - Disclosure - Fair Value Measurements - Schedule of Milestone Warrant Liability (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/EquityMethodInvestmentsDetails" id="EquityMethodInvestmentsDetails">
        <link:definition>996335 - Disclosure - Equity Method Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/EquityMethodInvestmentsScheduleofEquityMethodInvestmentDetails" id="EquityMethodInvestmentsScheduleofEquityMethodInvestmentDetails">
        <link:definition>996336 - Disclosure - Equity Method Investments - Schedule of Equity Method Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AccruedExpensesDetails" id="AccruedExpensesDetails">
        <link:definition>996337 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/AccruedExpensesScheduleofAccruedExpensesDetails" id="AccruedExpensesScheduleofAccruedExpensesDetails">
        <link:definition>996338 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/ConvertiblePreferredStockDetails" id="ConvertiblePreferredStockDetails">
        <link:definition>996339 - Disclosure - Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityDetails" id="StockholdersEquityDetails">
        <link:definition>996340 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityScheduleofStockOptionActivityDetails" id="StockholdersEquityScheduleofStockOptionActivityDetails">
        <link:definition>996341 - Disclosure - Stockholders' Equity -Schedule of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityScheduleofBlackScholesValuationModeltoDeterminetheFairValueoftheOptionsIssuedDetails" id="StockholdersEquityScheduleofBlackScholesValuationModeltoDeterminetheFairValueoftheOptionsIssuedDetails">
        <link:definition>996342 - Disclosure - Stockholders' Equity - Schedule of Black Scholes Valuation Model to Determine the Fair Value of the Options Issued (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityScheduleofStockBasedCompensationExpenseDetails" id="StockholdersEquityScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>996343 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityScheduleofRestrictedStockUnitsDetails" id="StockholdersEquityScheduleofRestrictedStockUnitsDetails">
        <link:definition>996344 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/StockholdersEquityScheduleofActivityinWarrantsDetails" id="StockholdersEquityScheduleofActivityinWarrantsDetails">
        <link:definition>996345 - Disclosure - Stockholders' Equity - Schedule of Activity in Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/CommitmentsandContingenciesDetails" id="CommitmentsandContingenciesDetails">
        <link:definition>996346 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/SegmentReportingDetails" id="SegmentReportingDetails">
        <link:definition>996347 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://adialpharma.com/20260630/role/SegmentReportingScheduleofSignificantSegmentExpensesDetails" id="SegmentReportingScheduleofSignificantSegmentExpensesDetails">
        <link:definition>996348 - Disclosure - Segment Reporting - Schedule of Significant Segment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="adil_GeneralAndAdministrativeOptionsExpenseMember" name="GeneralAndAdministrativeOptionsExpenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ResearchAndDevelopmentOptionsExpenseMember" name="ResearchAndDevelopmentOptionsExpenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_RestrictedStockExpenseMember" name="RestrictedStockExpenseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_StatementOfIncomeBalanceAxis" name="StatementOfIncomeBalanceAxis" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_StatementOfIncomeBalanceDomain" name="StatementOfIncomeBalanceDomain" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_TotalGeneralAndAdministrativeExpensesMember" name="TotalGeneralAndAdministrativeExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_TotalResearchAndDevelopmentExpensesMember" name="TotalResearchAndDevelopmentExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_PreFundedWarrantMember" name="PreFundedWarrantMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ScheduleOfActivityInWarrantsAbstract" name="ScheduleOfActivityInWarrantsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExercised" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_AcquiredInProcessResearchAndDevelopment" name="AcquiredInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_LicenseFeesAndMilestonePaymentsDescription" name="LicenseFeesAndMilestonePaymentsDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExpired" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWeightedAverageExercisePriceExpired" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsExercised" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsExpired" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsExpired" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_CODMMember" name="CODMMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_FairValueOfConsiderationTransferredTableTextBlock" name="FairValueOfConsiderationTransferredTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_CombinedPrice" name="CombinedPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="adil_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_InitialClosingPreFundedWarrantMember" name="InitialClosingPreFundedWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ExchangeAgreementsMember" name="ExchangeAgreementsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_PreFundedWarrantsMember" name="PreFundedWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_RedeemableConvertiblePreferredStockAbstract" name="RedeemableConvertiblePreferredStockAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AdialsPipelineMember" name="AdialsPipelineMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AggregatePurchasePrice" name="AggregatePurchasePrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_AggregateSharesOfCompany" name="AggregateSharesOfCompany" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="adil_NewlyIssuedShares" name="NewlyIssuedShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_ScheduleOfRestrictedStockUnitsLineItems" name="ScheduleOfRestrictedStockUnitsLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_MeasurementInputProbabilityOfMilestoneAchievementMember" name="MeasurementInputProbabilityOfMilestoneAchievementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_InitialFairValueOfWarrantsIssued" name="InitialFairValueOfWarrantsIssued" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_ChangeInFairValueRecognizedInNetLoss" name="ChangeInFairValueRecognizedInNetLoss" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_WarrantsExercisedOrSettledDuringThePeriod" name="WarrantsExercisedOrSettledDuringThePeriod" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_FinancingExpenseRelatedToMilestoneWarrantRightsLiability" name="FinancingExpenseRelatedToMilestoneWarrantRightsLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_IssuanceCostsFromThePrivatePlacementIssuanceOfPrefundedWarrantsIncludedInAccountsPayable" name="IssuanceCostsFromThePrivatePlacementIssuanceOfPrefundedWarrantsIncludedInAccountsPayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_AdjustmentsToAdditionalPaidInCapitalStockIssuancesToVendor" name="AdjustmentsToAdditionalPaidInCapitalStockIssuancesToVendor" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_GoingConcernAndOtherUncertaintiesAbstract" name="GoingConcernAndOtherUncertaintiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ReverseStockSplitMember" name="ReverseStockSplitMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_StockIssuedDuringPeriodValueIssuanceOfPreFundedWarrantsInConnectionWithPrivatePlacementTransaction" name="StockIssuedDuringPeriodValueIssuanceOfPreFundedWarrantsInConnectionWithPrivatePlacementTransaction" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_StockIssuedDuringPeriodValueIssuanceOfSeriesARedeemableConvertiblePreferredStockAndCommonStock" name="StockIssuedDuringPeriodValueIssuanceOfSeriesARedeemableConvertiblePreferredStockAndCommonStock" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_StockIssuedDuringPeriodSharesIssuanceOfSeriesARedeemableConvertiblePreferredStockAndCommonStock" name="StockIssuedDuringPeriodSharesIssuanceOfSeriesARedeemableConvertiblePreferredStockAndCommonStock" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_TemporaryEquitySeriesAConvertiblePreferredStockMember" name="TemporaryEquitySeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AzoraTherapeuticsMember" name="AzoraTherapeuticsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_InducementGrantsMember" name="InducementGrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_PortionOfOperatingLossesRecognized" name="PortionOfOperatingLossesRecognized" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_ProportionateShareOfDilutionToNewInvestors" name="ProportionateShareOfDilutionToNewInvestors" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_RestrictedStockAwardMember" name="RestrictedStockAwardMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_RestrictedStockUnitsAndAwardsMember" name="RestrictedStockUnitsAndAwardsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_NewlyIssuedShare" name="NewlyIssuedShare" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCompensationAndEmployeeBenefitsLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCompensationAndEmployeeBenefitsLiabilities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConvertiblePromissoryNotes" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConvertiblePromissoryNotes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInProcessResearchAndDevelopment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_AssumedOptionsMember" name="AssumedOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AzoraTherapeuticsLLCMember" name="AzoraTherapeuticsLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AcquisitionOfAzoraAndPipeIssuanceAbstract" name="AcquisitionOfAzoraAndPipeIssuanceAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_AcquisitionOfAzoraAndPipeIssuanceTextBlock" name="AcquisitionOfAzoraAndPipeIssuanceTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_NetCashAssumedInTheAcquisitionOfAzoraTherapeutics" name="NetCashAssumedInTheAcquisitionOfAzoraTherapeutics" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="adil_PercentageOfWeightedAverageEquity" name="PercentageOfWeightedAverageEquity" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_GoingConcernAndOtherUncertaintiesTable" name="GoingConcernAndOtherUncertaintiesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_GoingConcernAndOtherUncertaintiesLineItems" name="GoingConcernAndOtherUncertaintiesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ConversionOfTheAzoraTherapeuticsConvertiblePromissoryNotesToPrefundedWarrants" name="ConversionOfTheAzoraTherapeuticsConvertiblePromissoryNotesToPrefundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_MilestoneRightsLiabilityPolicyTextBlock" name="MilestoneRightsLiabilityPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_VolumeWeightedAverageStockPriceRate" name="VolumeWeightedAverageStockPriceRate" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_ProbabilityOfAchieving" name="ProbabilityOfAchieving" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_CashReceiptFromContingentConsideration" name="CashReceiptFromContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_ChangeInFairValueContingentConsideration" name="ChangeInFairValueContingentConsideration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_RightToPurchaseMilestoneWarrantsInAssociationWithThePrivatePlacementIssuanceOfThePreFundedWarrants" name="RightToPurchaseMilestoneWarrantsInAssociationWithThePrivatePlacementIssuanceOfThePreFundedWarrants" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_AdovatesEquityMember" name="AdovatesEquityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_PurnovateIncMember" name="PurnovateIncMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ReverseStockSplitPolicyTextBlock" name="ReverseStockSplitPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_PreclinicalAndManufacturingExpenses" name="PreclinicalAndManufacturingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="adil_AttheMarketOfferingAgreementTwentyTwentyFiveMember" name="AttheMarketOfferingAgreementTwentyTwentyFiveMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_ScheduleOfEquityMethodInvestmentAbstract" name="ScheduleOfEquityMethodInvestmentAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_FormerAzoraStockholdersMember" name="FormerAzoraStockholdersMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_FixedCommissionRateOnSaleOfCommonStock" name="FixedCommissionRateOnSaleOfCommonStock" type="dtr:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="adil_StandbyEquityPurchaseAgreementMember" name="StandbyEquityPurchaseAgreementMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="adil_TwoThousandSeventeenEquityIncentivePlanMember" name="TwoThousandSeventeenEquityIncentivePlanMember" type="dtr:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xs:schema>
